Company news
Neovasc Inc news in 2019
Neovasc Inc's news releases, calls and decks from 2019, newest first.
Neovasc Announces Pricing of $5 Million Public Offering of Common Shares
March 13, 2019
Neovasc Announces Proposed Public Offering of Common Shares
March 12, 2019
Neovasc Announces Agreements to Exchange Outstanding Warrants for Shares
March 12, 2019
Neovasc Announces Reducer(TM) Implant "Live Case" at the CRT Meeting in Washington, DC
March 5, 2019
Neovasc's Tiara(TM) Mitral Valve Replacement Technology Featured in Update Presentation at the CRT 2019 Meeting
March 4, 2019
Neovasc announces closing of $5 million public offering of common shares
February 28, 2019
Neovasc to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference
February 27, 2019
Neovasc Announces Pricing of $5 Million Public Offering of Common Shares
February 26, 2019
Neovasc Announces Proposed Public Offering of Common Shares
February 25, 2019
Neovasc Announces Refiling of Interim Financial Statements and Management's Discussion and Analysis for the Period Ended September 30, 2018
February 22, 2019
Neovasc Celebrates 5-Year Anniversary of Tiara Patient as the Longest Surviving Transcatheter Mitral Valve Replacement in the World
February 21, 2019
Neovasc Provides Corporate Update
February 20, 2019
Pierangeli Clinic Initiates Program Providing Neovasc Reducer(TM) Procedure to Italian Patients with Refractory Angina
February 11, 2019
Neovasc Announces Renewal of German NUB Status 1 Designation for Neovasc Reducer(TM) Procedure for Treatment of Refractory Angina
January 30, 2019
Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK
January 29, 2019
Neovasc announces peer reviewed publication in JACC demonstrating objective evidence of improvement in perfusion after Reducer implantation
January 23, 2019
Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences
January 22, 2019
Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
January 14, 2019
Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency
January 3, 2019